37 research outputs found

    Investigating the Cosmic-Ray Ionization Rate in the Galactic Diffuse Interstellar Medium through Observations of H3+

    Full text link
    Observations of H3+ in the Galactic diffuse interstellar medium (ISM) have led to various surprising results, including the conclusion that the cosmic-ray ionization rate (zeta_2) is about 1 order of magnitude larger than previously thought. The present survey expands the sample of diffuse cloud sight lines with H3+ observations to 50, with detections in 21 of those. Ionization rates inferred from these observations are in the range (1.7+-1.3)x10^-16 s^-1<zeta_2<(10.6+-8.2)x10^-16 s^-1 with a mean value of zeta_2=(3.5^+5.3_-3.0)x10^-16 s^-1. Upper limits (3 sigma) derived from non-detections of H3+ are as low as zeta_2<0.4x10^-16 s^-1. These low upper-limits, in combination with the wide range of inferred cosmic-ray ionization rates, indicate variations in zeta_2 between different diffuse cloud sight lines. A study of zeta_2 versus N_H (total hydrogen column density) shows that the two parameters are not correlated for diffuse molecular cloud sight lines, but that the ionization rate decreases when N_H increases to values typical of dense molecular clouds. Both the difference in ionization rates between diffuse and dense clouds and the variation of zeta_2 among diffuse cloud sight lines are likely the result of particle propagation effects. The lower ionization rate in dense clouds is due to the inability of low-energy (few MeV) protons to penetrate such regions, while the ionization rate in diffuse clouds is controlled by the proximity of the observed cloud to a site of particle acceleration.Comment: 48 pages, 19 figures, 4 tables, accepted for publication in Ap

    Investigating the Cosmic-Ray Ionization Rate Near the Supernova Remnant IC 443 Through H3+ Observations

    Get PDF
    Observational and theoretical evidence suggests that high-energy Galactic cosmic rays are primarily accelerated by supernova remnants. If also true for low-energy cosmic rays, the ionization rate near a supernova remnant should be higher than in the general Galactic interstellar medium (ISM). We have searched for H3+ absorption features in 6 sight lines which pass through molecular material near IC 443---a well-studied case of a supernova remnant interacting with its surrounding molecular material---for the purpose of inferring the cosmic-ray ionization rate in the region. In 2 of the sight lines (toward ALS 8828 and HD 254577) we find large H3+ column densities, N(H3+)~3*10^14 cm^-2, and deduce ionization rates of zeta_2~2*10^-15 s^-1, about 5 times larger than inferred toward average diffuse molecular cloud sight lines. However, the 3 sigma upper limits found for the other 4 sight lines are consistent with typical Galactic values. This wide range of ionization rates is likely the result of particle acceleration and propagation effects, which predict that the cosmic-ray spectrum and thus ionization rate should vary in and around the remnant. While we cannot determine if the H3+ absorption arises in post-shock (interior) or pre-shock (exterior) gas, the large inferred ionization rates suggest that IC 443 is in fact accelerating a large population of low-energy cosmic rays. Still, it is unclear whether this population can propagate far enough into the ISM to account for the ionization rate inferred in diffuse Galactic sight lines.Comment: 14 pages, 3 figures, 4 table

    The diagnosis and management of anaphylaxis practice parameter: 2010 Update

    Get PDF
    These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American College of Allergy, Asthma & Immunology (ACAAI); and the Joint Council of Allergy, Asthma and Immunology. The AAAAI and the ACAAI have jointly accepted responsibility for establishing “The Diagnosis and Management of Anaphylaxis Practice Parameter: 2010 Update.” This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, or the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion

    Death due to asthma

    Get PDF
    The prevalence and fatality rate of asthma have increased worldwide. Underdiagnosis and undertreatment of asthma are central to the occurrence of fatal asthma. Atopy is the principal risk factor associated with asthma. However, consideration of the epidemiologic, physiologic, pharmacologic, pathologic and clinical parameters of asthma assessment may provide valuable insight into death due to asthma. Psychologic and socioeconomic factors may further aggravate the asthma status. Ethnic minorities are at increased risk of asthma. The perception of dyspnea may be blunted in asthma sufferers. Slow-onset fatal asthma may be associated with submucosal eosinophilic, whereas sudden-onset may be associated with submucosal neutrophilia. Fatal asthma occurs in patients abusing regular |32-agonist therapy. Peak flow assessment often provides insight into asthma deterioration prior to signs of respiratory distress. Markers of risk of death due to asthma further identify the fatality-prone asthma patient

    Joint Modeling and Simulations System (JMASS) prototype electro-optical/infrared environment environment player software design and development

    No full text
    Issued as final reportThis item was temporarily removed from SMARTech at the request of the Georgia Tech Research Institute on May 8, 2009

    Hereditary angioedema: Optimal therapy

    No full text

    Parents' Guide to Allergy in Children

    No full text
    corecore